wegovy

Weight loss jab alert as ban decision made after ‘irresponsible’ move

by

Weight Loss Jabs Under Scrutiny: Advertising Crackdown Signals a Shift The advertising landscape for weight loss medication is undergoing a significant change. The Advertising Standards Authority (ASA) has recently banned several advertisements for Juniper, an online pharmacy, for promoting prescription-only weight-loss medication and exploiting insecurities, particularly among new mothers. This ruling, made on April 8, … Read more

GLP‑1 drugs may do more than control blood sugar and weight

by

Beyond Weight Loss: The Expanding Promise of GLP-1 Medications Drugs like Ozempic and Wegovy, initially designed to manage type 2 diabetes, are now revealing a broader spectrum of potential health benefits. While widely recognized for their impact on weight loss and blood sugar control, emerging research suggests these GLP-1 receptor agonists could address a range … Read more

Ozempic Goes Generic —But Not in the US

by

Ozempic’s Patent Cliff: A Global Shift in Diabetes and Weight Loss Treatment A pivotal moment is unfolding in the pharmaceutical landscape as patent protections for semaglutide – the active ingredient in both Ozempic (for diabetes) and Wegovy (for weight loss) – expire in key global markets. This expiration, beginning Saturday, March 28, 2026, is poised … Read more

FDA sends letter to Novo Nordisk over potential GLP-1 side effects

by

FDA Scrutinizes Novo Nordisk: Reporting Lapses and Rising Safety Concerns with Ozempic & Wegovy The FDA recently issued a warning letter to Novo Nordisk, the manufacturer of Ozempic and Wegovy, citing failures to adequately report potential adverse effects and deaths linked to the popular GLP-1 medications. This action underscores growing scrutiny surrounding these drugs as … Read more

Experts discover a new threat from weight loss drugs

by

Weight-Loss Drugs and Vision Loss: What the Latest Research Reveals Recent studies are raising concerns about a potential link between semaglutide-based weight-loss medications, like Wegovy and Ozempic, and an increased risk of ischemic optic neuropathy (ION), a condition that can lead to vision loss. While the research is preliminary, it’s prompting closer scrutiny of these … Read more

Beware the peptide Übermensch – UnHerd

by

The Peptide Revolution: Beyond Ozempic and Biohacking The pursuit of self-optimization is no longer confined to gym routines and mindful meditation. A quiet revolution is underway, fueled by peptides – short chains of amino acids increasingly sought after for everything from weight loss to enhanced recovery and even, some believe, extending lifespan. What was once … Read more

After taking weight-loss drugs, have a plan to keep fit

by

Beyond the Shot: The Future of Weight Loss and Maintaining Results Ozempic, Wegovy, and similar GLP-1 medications have revolutionized weight loss, but lasting success hinges on a shift towards holistic health strategies. Updated: February 2, 2026 The dramatic weight loss achieved by patients using medications like Ozempic and Wegovy has captured public attention, offering hope … Read more

Recent guidelines on weight-loss drugs are a ‘groundbreaking’ shift in obesity treatment – The Irish Times

by

The Weight of Change: How New Drugs and a Reframed Understanding are Reshaping Obesity Treatment The conversation around weight loss has fundamentally shifted. For decades, the focus remained squarely on willpower and lifestyle changes. Now, thanks to the arrival of GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and a landmark shift in perspective from the … Read more

Food science and human nutrition professor offers tips for those taking GLP-1 medications

by

Beyond Ozempic: The Future of GLP-1s and Nutritional Harmony The buzz around medications like Ozempic and Wegovy is undeniable. These GLP-1 receptor agonists have revolutionized weight management for many, but their success isn’t simply about a shot. As University of Maine professor Mary Ellen Camire emphasizes, these drugs are a tool, not a miracle. The … Read more

GLP-1 drugs transforming obesity and diabetes care in San Antonio

by

The GLP-1 Revolution: Beyond Weight Loss, What’s Next for These Game-Changing Drugs? The buzz around medications like Ozempic, Wegovy, and Mounjaro is reaching a fever pitch. Initially hailed for their dramatic effects on weight loss, GLP-1 receptor agonists are now revealing a far broader range of potential health benefits. But what does the future hold … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]